LAB· Standard Biotools Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 5 quarters
LAB Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$398M
Enterprise value-$28M
EV / EBITDA (TTM)0.40
P/E ratio (TTM)—
Forward P/E-34.00
P/S ratio4.62
P/B ratio0.71
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$91M
Free cash flow (TTM)-$13M
Total cash$455M
Total debt$29M
Debt / equity5.26
Current ratio12.36
Income Statement
Total revenue (TTM)$86M
Revenue per share (TTM)0.23
Gross profit (TTM)$46M
EBITDA (TTM)-$68M
Net income (TTM)-$50M
EPS diluted (TTM)-0.13
Shares outstanding390,368,119
Float shares216,771,416
Profitability
Gross margin53.27%
Operating margin-44.53%
EBITDA margin-79.08%
Net margin90.67%
Efficiency
Return on assets (TTM)-8.05%
Return on equity (TTM)-9.86%
Price History
Current price$1.02
52 Week high$1.72
52 Week low$0.87
50 day average$0.95
200 day average$1.24
Average volume (10 day)2,381,540
1-year beta1.31
1-year price target$1.55
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:39 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com